Chemical Structure : GSK269962A
CAS No.: 850664-21-0
货号: PC-24391Not For Human Use, Lab Use Only.
GSK269962A is a potent, selective Rho kinase (ROCK) inhibitor with IC50 of 1.6 nM (recombinant human ROCK1), 30-fold selectivity against a panel of serine/threonine kinases.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥580 | In stock | |
10 mg | ¥880 | In stock | |
25 mg | ¥1480 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GSK269962A is a potent, selective Rho kinase (ROCK) inhibitor with IC50 of 1.6 nM (recombinant human ROCK1), 30-fold selectivity against a panel of serine/threonine kinases.
GSK269962 blocked the generation of inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-stimulated monocytes.
GSK269962A induced vasorelaxation in preconstricted rat aorta with an IC50 of 39 and 35 nM, respectively.
GSK269962 produced a profound dose-dependent reduction of systemic blood pressure in spontaneously hypertensive rats, induced a reduction in blood pressure of approximately 10, 20, and 50 mm Hg at 1, 3, and 30 mg/kg.
分子量 | 570.61 | |
分子式 | C29H30N8O5 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4, 5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]-oxy}benzamide |
1. Smith GK, et al. J Pharmacol Exp Ther. 2007 Jan;320(1):89-98.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright